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Summary
The objective of this study is to test the hypothesis that
quantitative measures of myocardial fibrosis such as the
myocardial extravascular extracellular volume fraction
(Ve) are associated with markers of adverse cardiac
remodeling such as the left atrial volume index (LAVi)
and left ventricular sphericity index (Si).
Background
LAVi and Si are intermediate phenotypes that precede
adverse outcomes. Myocardial fibrosis is quantifiable
with contemporary CMR techniques, is treatable, and
may represent a therapeutic target when these inter-
mediate phenotypes are present.
Methods
We measured myocardial Ve in 267 individuals referred
for CMR without confounders such as myocardial
infarction, where Ve= [lr(1-Hct) - Vp]; the specific
density of myocardial tissue, r=1.05; the myocardial
plasma volume fraction, Vp=0.045, and l=ΔR1myocar-
dium/ ΔR1blood. T1 was measured with an ECG-gated
MOLLI sequence acquired before and 20 minutes after
a gadolinium contrast bolus (0.2 mmol/kg). LAVi and Si
were measured from standard SSFP cine images: LAVi =
[8/3π [(A1)(A2)/L] where A1 and A2 are LA areas from
end-systolic 2-chamber and 4-chamber views, L repre-
sents the shortest anteroposterior LA dimension from
either view, and Si =EDV/[LAX^3 π /6), where EDV is
the end-diastolic volume measured from short axis
stacks and LAX^3 is the cube of the long axis diastolic
dimension from a 4 chamber view. Multivariable linear
regression models quantified the association of Ve with
LAVi and Si, adjusting for key characteristics identified
by stepwise selection.
Results
Ve was associated with LAVi (t value 4.5, p<0.001), and
this association remained after adjusting for age, ejection
fraction, EDV index, and left ventricular mass index (t
value 2.8, p=0.005). Ve was also associated with Si (t
value 5.6, p<0.001), and this association remained after
adjusting for age, gender, EDV index, body mass index,
and left ventricular mass index (t value 2.18, p=0.036).
Conclusions
Ve is associated with key intermediate phenotypes that
indicate adverse cardiac remodeling such as LAVi and
Si.
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